Artificial intelligence can provide paths for pharmaceutical firms to cut costs and time for getting additional OTC as well as Rx drugs to market. Their first step, says the CEO of a pharmaceutical AI developer, is determining the questions they need to answer.
“I ask people, what is the problem that you want me to solve instead of what kind of AI do you want to use? It's a simple change in the...
The San Francisco-based firm Varshney founded in 2017 uses generative AI for questions such as how to change the chemistry of a drug molecule, while machine learning, or deep learning...